Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

C4 Therapeutics Inc (CCCC)

C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
C4 Therapeutics Appoints Steve Hoerter to Board of Directors to Strengthen Oncology Expertise

C4 Therapeutics appoints Steve Hoerter to its Board, enhancing oncology expertise to advance targeted protein degradation innovations.Quiver AI SummaryC4 Therapeutics, Inc. has announced the appointment...

CCCC : 4.01 (unch)
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors

CCCC : 4.01 (unch)
C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial

CCCC : 4.01 (unch)
C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual Meeting

CCCC : 4.01 (unch)
C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

CCCC : 4.01 (unch)
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CCCC : 4.01 (unch)
C4 Therapeutics Appoints Paige Mahaney, Ph.D., as Chief Scientific Officer and Announces Retirement of Stewart Fisher, Ph.D.

CCCC : 4.01 (unch)
C4 Therapeutics Announces Presentations and Participation in 7th Annual Targeted Protein Degradation & Induced Proximity Summit

CCCC : 4.01 (unch)
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults

/CNW/ -- USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale...

ONCY : 1.0200 (+4.08%)
TCRX : 3.94 (-4.37%)
BMY : 58.30 (+0.12%)
PDSB : 2.21 (+0.23%)
CCCC : 4.01 (unch)
ONC.TO : 1.37 (-2.14%)
Global Efforts Intensify to Address Surging Young Adult Colorectal and Anal Cancer Rates

USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale Medicine. As well, there are now alarming reports around...

ONCY : 1.0200 (+4.08%)
ONC.TO : 1.37 (-2.14%)
TCRX : 3.94 (-4.37%)
BMY : 58.30 (+0.12%)
PDSB : 2.21 (+0.23%)
CCCC : 4.01 (unch)

Barchart Exclusives

1 'Strong Buy' AI Server Stock to Buy Instead of Super Micro Computer
Down 25% from record highs, Dell Technologies is positioned to benefit from the AI megatrend, making it a top stock to own, compared to Super Micro Computer. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar